Astrocytic Mechanisms in Temporal Lobe Epilepsy

Astrocytes have emerged as active players in the pathogenesis of temporal lobe epilepsy. Once considered passive support cells, they are now recognised for their roles in ion homeostasis, neurotransmitter clearance, metabolic support and neuroinflammation. In the epileptic hippocampus, astrocytes undergo reactive astrogliosis, characterised by morphological changes, altered expression of glial fibrillary acidic protein and dysregulated release of cytokines. These changes can disrupt extracellular potassium buffering, impair glutamate uptake and exacerbate neuronal hyperexcitability. Mitochondrial dysfunction in astrocytes leads to lipid accumulation and further metabolic stress, while epigenetic modifications, such as m6A methylation, can upregulate key transporters that govern glutamate exchange. Aberrant signalling through ion channels such as TRPV4 and altered activity of pumps and receptors—including Na+-K+-ATPase and adenosine receptors—modulate the seizure threshold. Collectively, these astrocytic mechanisms contribute to an environment conducive to recurrent seizures and the progression to drug-resistant temporal lobe epilepsy. Advances in understanding these processes hold promise for novel therapeutic strategies targeting glial cells rather than neurons alone.

Research from Nature Portfolio

Recent studies have demonstrated that direct optogenetic stimulation of astrocytes can attenuate seizure activity in cortical models. Activation of channelrhodopsin-expressing astrocytes enhances Na+-K+-ATPase-mediated potassium uptake, thereby rebalancing ionic gradients and dampening hyperactive neuronal firing. This approach exhibited a wider therapeutic window and sustained efficacy with minimal off-target effects, and it proved effective in a chronic focal cortical dysplasia model. These findings establish astrocytic Na+-K+-ATPase as a potential target for intractable epilepsy and challenge the neurocentric view by emphasising the anti-seizure capacity of glial modulation.

Astrocytic Mechanisms in Temporal Lobe Epilepsy publication trend

The graph below shows the total number of articles in astrocytic mechanisms in temporal lobe epilepsy across all publications each year (not limited to Nature Index journals).

Technical terms

Reactive astrogliosis: A spectrum of morphological and functional changes in astrocytes in response to injury or disease.

Glutamate–cystine antiporter (xCT): A membrane transporter that exchanges extracellular cystine for intracellular glutamate, influencing excitatory neurotransmission.

m6A methylation: A reversible chemical modification of RNA that affects mRNA stability and translation.

YTHDC2: An m6A reader protein that recognises methylated mRNA and regulates its expression.

TRPV4: A calcium-permeable transient receptor potential channel involved in astrocytic signalling and inflammation.

Adenosine A1 receptor: A G protein-coupled receptor that mediates inhibitory neuromodulation and influences seizure susceptibility.

Na+-K+-ATPase: A membrane-bound enzyme that maintains ionic gradients by pumping sodium out and potassium into cells, crucial for controlling extracellular potassium levels during neuronal activity.

References

1. The m6A reader YTHDC2 promotes the pathophysiology of temporal lobe epilepsy by modulating SLC7A11-dependent glutamate dysregulation in astrocytes. Theranostics (2024).
2. Cell-specific NFIA upregulation promotes epileptogenesis by TRPV4-mediated astrocyte reactivity. Journal of Neuroinflammation (2023).
3. Mitochondrial Dysfunction of Astrocytes Mediates Lipid Accumulation in Temporal Lobe Epilepsy. Aging and Disease (2023).
4. Agrin-Lrp4 pathway in hippocampal astrocytes restrains development of temporal lobe epilepsy through adenosine signaling. Cell & Bioscience (2024).
5. Activated astrocytes attenuate neocortical seizures in rodent models through driving Na+-K+-ATPase. Nature Communications (2022).